Rockwell Medical, Inc. Q3 2025 Earnings Recap

Rockwell Medical reported a profitable third quarter driven by strategic contract management and operational efficiencies, despite the anticipated impact from the transition of its largest customer.

Key Takeaways

• Achieved adjusted EBITDA profitability while net sales reached $15.9 million, aligning with full-year guidance.
• Maintained gross margins within the targeted range of 16% to 18%, showcasing stability amid customer transitions.
• Secured multiple long-term purchasing agreements, including a notable contract with a Southern Florida dialysis center expected to generate approximately $1 million in annual net sales.
• Continued supply to former largest customer, who represented 12% of sales, highlighting ongoing demand and the challenges of supplier transitions in critical healthcare services.
• Strengthened contract portfolio with over 80% of customers now under long-term agreements, enhancing revenue visibility and stability for future growth.